Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
April 18, 2024
Achieving the UN Sustainable Development Goals (SDGs) and addressing global challenges will require a step change in private investment in emerging markets and developing economies (EMDEs). Only a small fraction of the trillions in private assets under management are currently directed to EMDEs.
Blog Post
March 12, 2024
There is no way that poverty can be fully tackled without policies designed to address the multiple disadvantages faced by people due to the combination of ascribed attributes including gender, age, race, ethnicity, disability, migration status, and sexual orientation and gender identity (SOGI). And...
Blog Post
November 28, 2023
The central role that private investors must play in financing Sustainable Development Goals (SDG) investments in emerging markets and developing economies (EMDEs) is now widely understood and acknowledged. The just-published two-volume report of the Independent Experts Group (here and here) to the ...
Blog Post
October 30, 2023
Realizing the Sustainable Development Goals (SDGs) and tackling the climate crisis in developing nations demands substantial investments. A recent report commissioned by the G20 estimated that for developing countries (encompassing low-income, lower-middle-income, and upper-middle-income nations), a...
Blog Post
August 30, 2023
UN Secretary General Antonio Guterres prefaces the new UN report on the status of the Sustainable Development Goals (SDGs) at their midpoint with some despairing language. “Progress on more than 50 per cent of targets of the SDGs is weak and insufficient; on 30 per cent, it has stalled or gone into ...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.